Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study

Sponsor
The National Brain Mapping Laboratory (NBML) (Other)
Overall Status
Recruiting
CT.gov ID
NCT05200962
Collaborator
University of British Columbia (Other), Ruhr University of Bochum (Other), Leibniz Research Centre for Working Environment and Human Factors (Other), University of Tehran (Other)
30
1
2
12
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the mechanism of action of transcranial electrical brain stimulation over the dorsolateral prefrontal cortex for cognitive impairment in schizophrenia. To do so the effect of a novel stimulation protocol will be investigated in the fMRI scanner.

Condition or Disease Intervention/Treatment Phase
  • Device: transcranial direct current stimulation
Phase 1

Detailed Description

Thirty schizophrenic patients will be recruited after meeting the inclusion criteria and will be randomly assigned to active and sham stimulation groups. A single session of concurrent prefrontal tDCS/fMRI will be conducted. Participants will undergo baseline task performance before the intervention. One week later, they will undergo the tDCS intervention (active or sham) in the scanner during which they perform the working memory task varying in cognitive load. They will perform the task 12 and 24 h later again.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Official Title:
Investigating the Mechanism of Action of Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Aug 30, 2022
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active tDCS group

The experimental arm receives real (or active) electrical stimulation for 20 minutes

Device: transcranial direct current stimulation
In tDCS, direct electrical currents are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm).
Other Names:
  • tDCS
  • tES
  • Sham Comparator: sham tDCS group

    The sham arm receives sham (or no real) intervention in which stimulation lasts for 30 seconds and ends afterward.

    Device: transcranial direct current stimulation
    In tDCS, direct electrical currents are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm).
    Other Names:
  • tDCS
  • tES
  • Outcome Measures

    Primary Outcome Measures

    1. Working memory behavioral performance [up to 24 hours after the intervention]

      A computerized version of 3- back letter task, optimized for administration in a functional MRI environment will be employed during the experiment

    2. Modifications to blood-oxygen-level-dependent (BOLD) signal [up to 1 hour]

      Changes to blood-oxygen-level-dependent (BOLD) signal (arbitrary units) of brain areas that are implicated in cognitive impairment and pathophysiology of schizophrenia during the working memory task, as measured by fMRI following the intervention between the active and sham groups.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • men or women (18-50 yrs old) with a DSM 5 SCZ diagnosis,

    • If female, negative urine pregnancy test

    • significant cognitive impairment (1 SD below the norm on the working memory/executive functioning task performance)

    • feasibility for tDCS interventions according to safety guidelines

    • stable medication regime especially the classical neuroleptics and all CNS-activating medications, if taken, 4-6 weeks before the experiment

    • fluency in the native language

    • right-handed

    • ability to provide informed consent.

    Exclusion Criteria:
    • pregnancy

    • alcohol or substance dependence

    • history of seizure

    • history of neurological disorder

    • history of head injury

    • Presence of ferromagnetic objects in the body that are contraindicated for MRI of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments) or fear of enclosed spaces). Eligibility will be determined by the "MRI Safety Screening Questionnaire" and verified, if necessary, by a radiology consultant.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The National Brain Mapping Laboratory (NBML) Tehran Iran, Islamic Republic of

    Sponsors and Collaborators

    • The National Brain Mapping Laboratory (NBML)
    • University of British Columbia
    • Ruhr University of Bochum
    • Leibniz Research Centre for Working Environment and Human Factors
    • University of Tehran

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohammad Ali Salehinejad, Principal Investigator, Ruhr University of Bochum
    ClinicalTrials.gov Identifier:
    NCT05200962
    Other Study ID Numbers:
    • 2021_01_GF16
    First Posted:
    Jan 21, 2022
    Last Update Posted:
    Apr 5, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mohammad Ali Salehinejad, Principal Investigator, Ruhr University of Bochum
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 5, 2022